The Effect of ShenQi FuZheng Injection in Combination with Chemotherapy versus Chemotherapy Alone on the Improvement of Efficacy and Immune Function in Patients with Advanced Non-Small Cell Lung Cancer: A Meta-Analysis-Reference-Cited by-同舟云学术

The Effect of ShenQi FuZheng Injection in Combination with Chemotherapy versus Chemotherapy Alone on the Improvement of Efficacy and Immune Function in Patients with Advanced Non-Small Cell Lung Cancer: A Meta-Analysis

Published:2016-03-25 Issue:3 Volume:11 Page:e0152270
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

dedong Cao,huilin Xu,Anbing He,Ximing Xu,wei Ge

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference38 articles.

1. International trends in lung cancer incidence by histological subtype: adenocarcinoma stabilizing in men but still increasing in women;J Lortet-Tieulent;Lung cancer,2014

2. Lung cancer in China: challenges and interventions;J She;Chest,2013

3. Gefitinib or erlotinib as maintenance therapy in patients with advanced stage non-small cell lung cancer: a systematic review;X Chen;PloS one,2013

4. Meta-analysis on pharmacogenetics of platinum-based chemotherapy in non small cell lung cancer (NSCLC) patients;JY Yin;PloS one,2012

5. Understanding the function and dysfunction of the immune system in lung cancer: the role of immune checkpoints;N Karachaliou;Cancer biology & medicine,2015

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Network pharmacology-based investigation of the effects of Shenqi Fuzheng injection on glioma proliferation and migration via the SRC/PI3K/AKT signaling pathway;Journal of Ethnopharmacology;2024-06

2. Shenqi Fuzheng injection hinders non-small cell lung cancer cell growth by regulating the Bax/Bcl-2 signaling pathway;Discover Oncology;2024-05-29

3. Efficacy and safety of Shenqi Fuzheng injection combined with chemotherapy for cancer: An overview of systematic reviews;Phytomedicine;2024-03

4. Holistic immunomodulation for small cell lung cancer;Seminars in Cancer Biology;2023-01

5. Efficacy and safety of EGFR‑TKIs plus Shenqi Fuzheng injection for non-small cell lung cancer patients with EGFR-sensitive mutations;Journal of Cancer Research and Clinical Oncology;2022-08-26